newsfilter
← Latest News
GlobeNewswire·

Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF's Spring Clinical Meetings

WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet